{ "id": "epp2kpqnge", "slug": "injection-laryngoplasty", "title": "Injection laryngoplasty", "updated": "2026-10-15", "topic_path": [ { "id": "life", "label": "Life and health", "api_url": "https://www.edgepedia.org/api/v1/topics/life" }, { "id": "life.health", "label": "Human health and medicine", "api_url": "https://www.edgepedia.org/api/v1/topics/life.health" }, { "id": "life.health.clinical", "label": "Clinical assessment and procedures", "api_url": "https://www.edgepedia.org/api/v1/topics/life.health.clinical" }, { "id": "life.health.clinical.clinical-surgery", "label": "Surgery and surgical specialties", "api_url": "https://www.edgepedia.org/api/v1/topics/life.health.clinical.clinical-surgery" }, { "id": "life.health.clinical.clinical-surgery.head-and-neck-surgery-procedures", "label": "Head and neck surgery procedures", "api_url": "https://www.edgepedia.org/api/v1/topics/life.health.clinical.clinical-surgery.head-and-neck-surgery-procedures" } ], "geo": [ { "id": "geo.nongeo.t1946.life.health.clinical.clinical-surgery.head-and-neck-surgery-procedures", "label": "Non-geographic · 1946 to 2000: Head and neck surgery procedures", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.health.clinical.clinical-surgery.head-and-neck-surgery-procedures", "path": [ { "id": "geo.nongeo", "label": "Non-geographic", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo" }, { "id": "geo.nongeo.t1946", "label": "Non-geographic · 1946 to 2000", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946" }, { "id": "geo.nongeo.t1946.life", "label": "Life and health", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life" }, { "id": "geo.nongeo.t1946.life.health", "label": "Human health and medicine", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.health" }, { "id": "geo.nongeo.t1946.life.health.clinical", "label": "Clinical assessment and procedures", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.health.clinical" }, { "id": "geo.nongeo.t1946.life.health.clinical.clinical-surgery", "label": "Surgery and surgical specialties", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.health.clinical.clinical-surgery" }, { "id": "geo.nongeo.t1946.life.health.clinical.clinical-surgery.head-and-neck-surgery-procedures", "label": "Head and neck surgery procedures", "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.health.clinical.clinical-surgery.head-and-neck-surgery-procedures" } ] } ], "excerpt": "Injection laryngoplasty is a surgical technique for vocal fold insufficiency, first described in 1911, that injects temporary or long-lasting fillers to treat paralysis, atrophy, and scarring.", "snippet": "Injection laryngoplasty is a surgical technique for vocal fold insufficiency, first described in 1911, that injects temporary or long-lasting fillers to treat paralysis, atrophy, and scarring.", "node": "life.health.clinical.clinical-surgery.head-and-neck-surgery-procedures", "markdown": "# Injection laryngoplasty\n\nInjection laryngoplasty is a surgical technique for vocal fold insufficiency, historically performed as a transoral procedure under general anesthesia and now also done in awake patients via percutaneous, transoral, or transnasal approaches.[1](https://link.springer.com/content/pdf/10.1007/s40136-014-0038-9.pdf) Modern practice augments the fold for paralysis, paresis, atrophy, bowing, and scarring,[1](https://link.springer.com/content/pdf/10.1007/s40136-014-0038-9.pdf) either temporarily, while nerve function recovers, or permanently, using long-lasting fillers.[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC3010535/) In a survey covering 460 injections in 12 months, 51% were performed in awake, unsedated patients and 49% under general anesthesia.[3](https://onlinelibrary.wiley.com/doi/10.1002/lary.20737)\n\n| Key fact | Detail |\n|---|---|\n| First description | Bruening, 1911, transoral injection under general anesthesia; the oldest surgical technique for vocal fold insufficiency[1](https://link.springer.com/content/pdf/10.1007/s40136-014-0038-9.pdf) |\n| Indications (survey) | Paralysis 54%, paresis 21%, atrophy 15%, scar 10%[3](https://onlinelibrary.wiley.com/doi/10.1002/lary.20737) |\n| Glottic gap limit | Generally feasible for gaps up to 3 mm[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC3010535/) |\n| Longest-lasting approved filler | Calcium hydroxylapatite (Radiesse), average effect 18 months, persistence up to 2 years[4](https://pmc.ncbi.nlm.nih.gov/articles/PMC12650332/) |\n| Temporary fillers | Carboxymethylcellulose weeks to months; hyaluronic acid about 4–6 months[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC3010535/) • [1](https://link.springer.com/content/pdf/10.1007/s40136-014-0038-9.pdf) |\n| Awake vs operating room | Technical success 99% vs 97%; complications 3% vs 2%[3](https://onlinelibrary.wiley.com/doi/10.1002/lary.20737) |\n| Vs medialization thyroplasty | Comparable harmonic-to-noise ratio, maximum phonation time, and Voice Handicap Index improvement[5](https://link.springer.com/article/10.1007/s00405-025-09716-y) |\n\n## How it works\n\nThe technique is generally considered feasible for a glottic gap up to 3 mm; beyond that, insufficiency becomes increasingly difficult to correct by injection alone.[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC3010535/)\n\nPlacement depth determines the result. Material placed too superficially, in the subepithelial plane, sits in the vibrating cover of the fold and can worsen vibration; with calcium hydroxylapatite, a superficial injection causes inflammation and stiffness that may be permanent.[1](https://link.springer.com/content/pdf/10.1007/s40136-014-0038-9.pdf) • [2](https://pmc.ncbi.nlm.nih.gov/articles/PMC3010535/)\n\n## How it is done\n\nIn-office awake injection uses percutaneous (trans-cricothyroid membrane, trans-thyroid cartilage, and trans-thyrohyoid membrane), per-oral, and trans-nasal endoscopic approaches, usually visualized with a flexible distal-chip laryngoscope.[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC3010535/) For the percutaneous route, landmarks are localized by palpation and 0.5–1.0 mL of local anesthetic is infiltrated with a 30-gauge needle over the cricothyroid membrane; injection proceeds under flexible nasolaryngoscope visualization, often with an assistant holding the scope.[1](https://link.springer.com/content/pdf/10.1007/s40136-014-0038-9.pdf) • [6](https://theotorhinolaryngologist.co.uk/new/images/pdf/v6_n2/injection_laryngoplasty.pdf) In the cricothyroid approach, the needle is inserted at the cricothyroid notch and advanced supero-laterally through the cricothyroid membrane into the paraglottic area until the desired vocal fold position is achieved; patients are kept nil by mouth and observed for 1 hour.[6](https://theotorhinolaryngologist.co.uk/new/images/pdf/v6_n2/injection_laryngoplasty.pdf)\n\nRoute selection in local-anesthesia series favors the neck: among 634 patients undergoing a single technique, 79% were transcutaneous, 17% transoral, and 4% transnasal.[7](https://doi.org/10.1111/coa.14307) A 2025 technique article describes the transcervical cricothyroid approach as advancing a needle through the cricothyroid space into the inferior aspect of the vocal fold, with or without entering the airway, alongside peroral in-office options.[8](https://www.sciencedirect.com/science/article/abs/pii/S104318102500048X)\n\n## Origin\n\nThe procedure is a transoral injection under general anesthesia, and it remains the oldest surgical technique for vocal fold insufficiency.[1](https://link.springer.com/content/pdf/10.1007/s40136-014-0038-9.pdf) • [3](https://onlinelibrary.wiley.com/doi/10.1002/lary.20737) Robert B. Lewy reported the largest then-published series of Teflon-glycerin injection into paralyzed vocal cords in 1976, documenting the era's successes, failures, and complications.[9](https://doi.org/10.1177/000348947608500404) In 1985, Paul H. Ward, David G. Hanson, and Elliot Abemayor introduced the office-based transcutaneous approach, injecting under local anesthesia with video laryngoscopy.[10](https://doi.org/10.1288/00005537-198506000-00002) • [1](https://link.springer.com/content/pdf/10.1007/s40136-014-0038-9.pdf) Paraffin, silicone, and Teflon were eventually abandoned because of granulomatous reactions, foreign-body inflammation, and high extrusion rates; long-term Teflon studies showed reactions often requiring removal with significant vocal fold tissue loss.[4](https://pmc.ncbi.nlm.nih.gov/articles/PMC12650332/) • [2](https://pmc.ncbi.nlm.nih.gov/articles/PMC3010535/) • [6](https://theotorhinolaryngologist.co.uk/new/images/pdf/v6_n2/injection_laryngoplasty.pdf) • [4](https://pmc.ncbi.nlm.nih.gov/articles/PMC12650332/) autologous fascia was reported with voice-acoustic outcomes in 1999.[4](https://pmc.ncbi.nlm.nih.gov/articles/PMC12650332/) • [11](https://doi.org/10.1097/00005537-199911000-00026)\n\n## Variants\n\nMaterials divide into temporary and long-lasting. Temporary fillers include bovine gelatin (Gelfoam, Surgifoam), lasting 4–6 weeks; collagen products (Cymetra, Zyplast, Cosmoplast/Cosmoderm); hyaluronic acid gels (Restylane, Hylaform), lasting a believed 4–6 months; and carboxymethylcellulose (Radiesse Voice Gel).[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC3010535/) Published CMC durations disagree: one review gives 4–12 weeks,[1](https://link.springer.com/content/pdf/10.1007/s40136-014-0038-9.pdf) another 2–3 months.[4](https://pmc.ncbi.nlm.nih.gov/articles/PMC12650332/) Long-lasting materials include autologous fat, calcium hydroxylapatite (Radiesse), polydimethylsiloxane, and historically polytef (Teflon).[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC3010535/)\n\nRadiesse (Radiesse Laryngeal Implant) is the only FDA-cleared (510(k), K070090, 2007) long-term injectable for vocal fold augmentation; no PMA-approved vocal fold filler exists. It consists of CaHA microspheres in a CMC carrier gel, with an average duration of 18 months and persistence up to 2 years; a multi-institutional trial showed 80% improvement at 12 months.[4](https://pmc.ncbi.nlm.nih.gov/articles/PMC12650332/) • [2](https://pmc.ncbi.nlm.nih.gov/articles/PMC3010535/) Autologous fat lasts one to several years (reported 26 months or more), but resorption is unpredictable, so overinjection is recommended; one protocol advises roughly 50% overinjection,[12](https://iowaprotocols.medicine.uiowa.edu/protocols/laryngeal-fat-injection-vocal-cord-paralysis-and-glottic-incompetence) while a recent review states approximately 30% overcorrection is often needed, a disagreement the literature has not settled.[4](https://pmc.ncbi.nlm.nih.gov/articles/PMC12650332/) • [6](https://theotorhinolaryngologist.co.uk/new/images/pdf/v6_n2/injection_laryngoplasty.pdf) Autologous fascia absorbs little and is collagen-rich but has lower viscoelasticity and needs deeper donor incisions.[4](https://pmc.ncbi.nlm.nih.gov/articles/PMC12650332/) Choice depends on the desired duration of correction, patient anatomy, pathology, and material properties.[13](https://journals.lww.com/international-journal-of-surgery/fulltext/2024/11000/determinants_of_clinical_response_to_injection.44.aspx)\n\nA microporous annealed particle (MAP) hydrogel scaffold achieved de novo tissue formation and long-term augmentation, addressing the limits of inflammatory microparticles in degradable carriers.[14](https://www.nature.com/articles/s41536-023-00281-8) A light-activatable implant releases dexamethasone when triggered by a 1064-nm near-infrared laser at 100 mW positioned about 1 mm from the fold in three 20-second cycles with 40-second intervals.[15](https://onlinelibrary.wiley.com/doi/10.1002/lary.70149) Next-generation biomaterials such as silk-HA composites and peptide-based hydrogels aim to combine biomechanical support with active tissue regeneration.[4](https://pmc.ncbi.nlm.nih.gov/articles/PMC12650332/)\n\n## Applications\n\nWhen recovery of mobility is uncertain, as in acute unilateral paralysis, injection with a short-duration material during the recovery window, in which spontaneous recovery can occur within 6–12 months from onset, alleviates voice symptoms and improves swallowing until function recovers; a 2010 review reported that many programs then used collagen derivatives because Gelfoam was perceived to resorb within about four weeks.[2](https://pmc.ncbi.nlm.nih.gov/articles/PMC3010535/) • [16](https://iowaprotocols.medicine.uiowa.edu/protocols/injection-laryngoplasty-vocal-fold-paralysis-and-glottic-incompetence) Early injection improved Voice-Related Quality-of-Life, Glottal Function Index, GRBAS, the Functional Outcome Swallowing Scale, and maximum phonation time, and may avoid a future type 1 thyroplasty.[17](https://journalotohns.biomedcentral.com/articles/10.1186/1916-0216-42-24)\n\nIn a 24-month cohort of 75 patients with unilateral paralysis, mean Voice Handicap Index change was 29.14 after CaHA and 22.88 after hyaluronic acid; glottal gap improved at 6, 12, and 24 months in both groups, and reintervention within 2 years was needed by 12.5% of CaHA and 9.3% of HA patients.[18](https://pubmed.ncbi.nlm.nih.gov/34537510/) Under local anesthesia, maximum phonation time improved by 4.57 ± 2.3 s across 278 measured patients.\n\nFor vocal fold scar, current injectables, cross-linked hyaluronic acid, autologous fat, collagen, and platelet-rich plasma, offer short-term improvement but often fail to restore long-term vibratory function.[19](https://www.tandfonline.com/doi/abs/10.1080/17425247.2025.2569640) PRP, a low-cost autologous source of growth factors, cytokines, chemokines, and fibrinogen, is injected into the superficial lamina propria by subepithelial infusion to mechanically expand the tissue.[20](https://www.bjorl.org/en-the-emerging-role-platelet-rich-plasma-articulo-S1808869425001600)\n\n## Limitations and alternatives\n\nThe main alternative for unilateral paralysis is medialization thyroplasty (type I, Isshiki), a framework procedure placing an implant outside the fold. A 2025 meta-analysis of 13 studies found injection favored jitter (long-term MD −0.70, 95% CI −1.00 to −0.41) while thyroplasty favored shimmer (long-term MD −2.51, P = 0.003), attributed to the procedures' different mechanics; harmonic-to-noise ratio (P = 0.3), maximum phonation time (P = 0.8), and Voice Handicap Index (P = 0.6) improvements were comparable within six months.[5](https://link.springer.com/article/10.1007/s00405-025-09716-y) An earlier meta-analysis of CaHA injection versus silicone thyroplasty found comparable voice improvement, with maximum phonation time rising from 7.40 to 13.00 s after injection and from 6.16 to 12.40 s after thyroplasty.[21](https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1177/0194599812464193) How injection compares with laryngeal reinnervation is not addressed by published head-to-head data in this literature.\n\nComplications are uncommon but include airway obstruction, hemorrhage, aspiration, and material misplacement; superficial subepithelial injection of CaHA can cause permanent inflammation and stiffness, and women are at higher risk because of a smaller larynx.[1](https://link.springer.com/content/pdf/10.1007/s40136-014-0038-9.pdf) The necessary overinjection in fat injection causes prolonged postoperative dysphonia for up to a few weeks.[1](https://link.springer.com/content/pdf/10.1007/s40136-014-0038-9.pdf)\n\n## References\n\n1. [Injection Laryngoplasty: Techniques and Choices of Fillers](https://link.springer.com/content/pdf/10.1007/s40136-014-0038-9.pdf)\n2. [Vocal Fold Injection: Review of Indications, Techniques, and Materials for Augmentation](https://pmc.ncbi.nlm.nih.gov/articles/PMC3010535/)\n3. [Current practice in injection augmentation of the vocal folds: Indications, treatment principles, techniques, and complications](https://onlinelibrary.wiley.com/doi/10.1002/lary.20737)\n4. [Regenerative Strategies for Vocal Fold Repair Using Injectable Materials](https://pmc.ncbi.nlm.nih.gov/articles/PMC12650332/)\n5. [Injection laryngoplasty versus medialization thyroplasty for unilateral vocal cord paralysis: a comprehensive systematic review and meta-analysis](https://link.springer.com/article/10.1007/s00405-025-09716-y)\n6. [Injection Laryngoplasty (The Otorhinolaryngologist, vol 6 no 2)](https://theotorhinolaryngologist.co.uk/new/images/pdf/v6_n2/injection_laryngoplasty.pdf)\n7. [Techniques of Injection Laryngoplasty Under Local Anaesthesia in Unilateral Vocal Fold Paralysis: A Systematic Review](https://doi.org/10.1111/coa.14307)\n8. [In Office Vocal Fold Injection Augmentation (Operative Techniques in Otolaryngology, 2025)](https://www.sciencedirect.com/science/article/abs/pii/S104318102500048X)\n9. [Robert B. Lewy (1976). Experience with Vocal Cord Injection. Annals of Otology Rhinology & Laryngology.](https://doi.org/10.1177/000348947608500404)\n10. [Paul H. Ward, David G. Hanson, Elliot Abemayor (1985). Transcutaneous teflon injection of the paralyzed vocal cord: A new technique. The Laryngoscope.](https://doi.org/10.1288/00005537-198506000-00002)\n11. [Heikki Rihkanen, Sari Lehikoinen‐Söderlund, Petri Reijonen (1999). Voice Acoustics After Autologous Fascia Injection for Vocal Fold Paralysis. The Laryngoscope.](https://doi.org/10.1097/00005537-199911000-00026)\n12. [Laryngeal Fat Injection for Vocal Cord Paralysis and Glottic Incompetence | Iowa Head and Neck Protocols](https://iowaprotocols.medicine.uiowa.edu/protocols/laryngeal-fat-injection-vocal-cord-paralysis-and-glottic-incompetence)\n13. [Determinants of clinical response to injection laryngoplasty in unilateral vocal fold paralysis: a systematic review and meta-analysis](https://journals.lww.com/international-journal-of-surgery/fulltext/2024/11000/determinants_of_clinical_response_to_injection.44.aspx)\n14. [De novo tissue formation using custom microporous annealed particle hydrogel provides long-term vocal fold augmentation](https://www.nature.com/articles/s41536-023-00281-8)\n15. [Vocal Fold Scar Treatment via Controlled Dexamethasone Delivery With a Light-Activatable Implant](https://onlinelibrary.wiley.com/doi/10.1002/lary.70149)\n16. [Injection Laryngoplasty for Vocal Fold Paralysis and Glottic Incompetence | Iowa Head and Neck Protocols](https://iowaprotocols.medicine.uiowa.edu/protocols/injection-laryngoplasty-vocal-fold-paralysis-and-glottic-incompetence)\n17. [Evaluating the timing of injection laryngoplasty for vocal fold paralysis in an attempt to avoid future type 1 thyroplasty](https://journalotohns.biomedcentral.com/articles/10.1186/1916-0216-42-24)\n18. [Comparison of 24-month voice outcomes after injection laryngoplasty with calcium hydroxylapatite or hyaluronic acid in patients with unilateral vocal fold paralysis](https://pubmed.ncbi.nlm.nih.gov/34537510/)\n19. [Future outcomes and current limitations of injectable implants for vocal fold scarring](https://www.tandfonline.com/doi/abs/10.1080/17425247.2025.2569640)\n20. [The emerging role of platelet-rich plasma subepithelial infusion for vocal fold scar, sulcus, and atrophy](https://www.bjorl.org/en-the-emerging-role-platelet-rich-plasma-articulo-S1808869425001600)\n21. [A Meta-analysis of Voice Outcome Comparing Calcium Hydroxylapatite Injection Laryngoplasty to Silicone Thyroplasty](https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1177/0194599812464193)\n\n---\n*Topic: Encyclopedia › Life and health › Human health and medicine › Clinical assessment and procedures › Surgery and surgical specialties › Head and neck surgery procedures*\n\n*Initially written Sep 29, 2026 · Edited: Oct 15, 2026*\n\n*Copyright 2026 EdgeChat AI, a subsidiary of Biostate AI.*\n\nLicense: Edgepedia Community License 1.0, https://www.edgepedia.org/edgepedia/license\n", "same_as": [], "url": "https://www.edgepedia.org/injection-laryngoplasty", "markdown_url": "https://www.edgepedia.org/injection-laryngoplasty.md", "license": { "name": "Edgepedia Community License 1.0", "url": "https://www.edgepedia.org/edgepedia/license", "summary": "Free with credit, commercial use included. AI training is open to everyone. For other uses, organizations over USD 100M in revenue or 100M monthly users license separately.", "spdx": "LicenseRef-Edgepedia-Community-1.0" }, "credit": "\"Injection laryngoplasty\", Edgepedia (EdgeChat), https://www.edgepedia.org/injection-laryngoplasty. Edgepedia Community License 1.0.", "credit_md": "\"[Injection laryngoplasty](https://www.edgepedia.org/injection-laryngoplasty)\", Edgepedia (EdgeChat), [https://www.edgepedia.org/injection-laryngoplasty](https://www.edgepedia.org/injection-laryngoplasty). [Edgepedia Community License 1.0](https://www.edgepedia.org/edgepedia/license).", "credit_html": "\"Injection laryngoplasty\", Edgepedia (EdgeChat), https://www.edgepedia.org/injection-laryngoplasty. Edgepedia Community License 1.0.", "speakable": "Injection laryngoplasty is a surgical technique for vocal fold insufficiency, first described in 1911, that injects temporary or long-lasting fillers to treat paralysis, atrophy, and scarring." }